Answers are grounded in this paper and cite their sources.
Background: Atrophic acne scars represent a prevalent dermatological challenge with significant cosmetic and psychosocial implications. While autologous platelet concentrates (APCs), such as platelet-rich plasma (PRP), are widely used to promote tissue repair, single-modality approaches often yield sub-optimal structural reconstruction in deep scarring. Objective: This review evaluates the biophysical mechanisms, release kinetics, and clinical efficacy of autologous platelet concentrates – specifically comparing classical PRP with advanced liquid platelet-rich fibrin (f-PRF/i-PRF) – both as monotherapy and within hybrid protocols combined with microneedling, subcision, and ablative fractional CO2 laser resurfacing. Methods: A comprehensive synthesis of current preclinical and clinical literature was conducted, analyzing the impact of centrifugation physics (relative centrifugal force, rotor geometry, chemical additives) on cellular viability and the structural remodeling cascade. Results: Liquid PRF modalities, prepared without exogenous anticoagulants, demonstrate superior biological kinetics compared to PRP, forming a three-dimensional bio-scaffold that enables sustained growth factor release (up to 10–14 days) and homogenous leukocyte migration. Clinical data unequivocally indicate that hybrid procedures outperform monotherapies. Synergizing physical interventions such as microneedling, CO2 laser resurfacing, or subcision with autologous cytokines markedly enhances neocollagenesis and extracellular matrix remodeling. Furthermore, combining APCs with physical modalities significantly reduces post-procedural erythema, edema, downtime, and the incidence of post-inflammatory hyperpigmentation. Conclusion: Advanced platelet-rich fibrin matrices represent a therapeutic evolution over traditional PRP, particularly in preventing fibrous re-anchoring during subcision and providing extended paracrine signaling. Establishing standardized centrifugation protocols and objective evaluation metrics remains essential to fully optimize APC-driven regenerative therapy in dermatological surgery.
No takes yet. Share an insight, caveat, or question.
Madrzak et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: